Pediatric and Developmental Pathology · 2017 · 12 citations · 13 references
MedicineHematologyPediatricsHematologic OncologyHematopathologyPediatric HematologyBone Marrow PathologyHematologic DisordersHematologic MalignanciesHematopoietic NeoplasmsPediatric HematopathologyPediatric LeukemiasBcr-abl InhibitorsBcr-abl1 Fusion GeneCytogenetics In Hematologic DiseaseLeukemia DiagnosticsMegakaryocytic DisordersMyeloid NeoplasmsMyeloid-to-erythroid RatioPediatric Bone Marrow Disorders
Pediatric chronic myelogenous leukemia is uncommon. We report a pediatric patient with chronic myelogenous leukemia presenting with a normal white blood cell count and no circulating immature myeloid cells. The patient presented with extreme thrombocytosis (platelet count range: 2175–3064 × 10 9 /L) noted incidentally. No splenomegaly was found. Examination of the bone marrow aspirate revealed normal cellularity and normal myeloid: erythroid ratio with marked megakaryocytic hyperplasia. Molecular studies on the bone marrow aspirate detected both the major BCR/ABL1 p210 fusion transcript (9280 copies; p210/ ABL1 ratio: 38.2%) and the minor p190 transcript (below limit of quantitation). The platelet count normalized within 2 weeks after treatment with the second-generation tyrosine kinase inhibitor dasatinib. Follow-up after 3 months revealed a 1.87 log reduction in p210 transcripts compared to diagnosis and no detectable p190 transcripts. This case highlights the need to include BCR/ABL1 fusion testing to accurately diagnose pediatric patients presenting with isolated thrombocytosis.
13
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach
Nobuko Hijiya, Kirk R. Schultz, Markus Metzler et al. · Blood · 2015 · 216 citations · Full text
Medicine, Oncology, Pediatrics +15
Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia
Frédéric Millot, Philippe Traoré, Joëlle Guilhot et al. · PEDIATRICS · 2005 · 128 citations
Medicine, Hematology, Pediatrics +13